Varicella-zoster virus does not significantly induce the cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle

Medical Microbiology and Immunology

Volumn 194, Issue 1-2, 2005, Pages 25-31

  Desloges, Nathalie ^a   Rahaus, Markus ^a   Wolff, Manfred H ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

2 5A RNase L; Cell defence mechanisms; RNase L inhibitor; rRNA cleavage; Varicella zoster virus

Indexed keywords

RIBONUCLEASE L;

ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CHAPERONINS; ENDORIBONUCLEASES; HERPESVIRUS 3, HUMAN; HUMANS; RNA, RIBOSOMAL; VIRUS REPLICATION;

EID: 11244255055     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-004-0220-7     Document Type: Article

References (23)

1. Al-khatib K, Williams BR, Silverman RH, Halford W, Carr DJ (2003) The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 313:126-135
2. Balachandra K, Thawaranantha D, Ayuthaya PI, Bhumisawasdi J, Shiraki K, Yamanishi K (1994) Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro. Southeast Asian J Trop Med Public Health 25:252-257
3. Banerjee S, An S, Zhou A, Silverman RH, Makino S (2000) RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol 74:8793-8802
4. Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T (1995) Cloning and characterization of a RNase L inhibitor. J Biol Chem 270:13308-13317
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Carr DJ, Al-khatib K, James CM, Silverman R (2003) Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J Neuroimmunol 141:40-46
7. Cayley PJ, Davies JA, McCullagh KG, Kerr IM (1984) Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur J Biochem 143:165-174
8. Dong B, Silverman RH (1995) 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270:4133-4137
9. Floyd-Smith G, Slattery E, Lengyel P (1981) Interferon action: RNA cleavage pattern of a (2′-5′) oligoadenylate-dependent endonuclease. Science 212:1030-1032
10. Förster E (1994) An improved general method to generate internal standards for competitive PCR. Biotechniques 16:18-20
11. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol 20:617-627
12. Kerr IM, Brown RE (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci USA 75:256-260
13. Martinand C, Salehzada T, Silhol M, Lebleu B, Bisbal C (1998) RNase L inhibitor (RLI) antisens constructions block partially the down-regulation of the 2-5A/RNase L pathway in encephalomyocarditis virus (EMCV)-infected cells. Eur J Biochem 254:238-247
14. Martinand C, Montavon C, Salehzada T, Silhol M, Lebleu B, Bisbal C (1999) RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73:290-296
15. Player MR, Wondrak EM, Bayly SF, Torrence PF (1998) Ribonuclease L, a 2-5A-dependent enzyme: purification to homogeneity and assays for 2-5A binding and catalytic activity. Methods 15:243-253
16. Rahaus M, Wolff MH (2003) Reciprocal effects of Varicella-zoster virus (VZV) and AP1: activation of jun, fos and ATF-2 after VZV infection and their importance for the regulation of viral genes. Virus Res 92:9-21
17. Rahaus M, Desloges N, Yang M, Ruyechan WT, Wolff MH (2003) Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication. J Gen Virol 84:2957-2967
18. Rolfs A, Schuller I, Finckh U, Weber-Rolfs I (1992) Reverse transcription/ PCR (RT-PCR). In: Rolfs A (ed) PCR: clinical diagnostics and research. Springer, Berlin Heidelberg New York, pp 99-102
19. Sato H, Callanan LD, Pesnicak L, Krogmann T, Cohen JI (2002) Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37°C but not 33°C. J Virol 76:11012-11023
20. Smith TJ, Silverman RH, Leib DA (2003) RNase L activity does not contribute to host RNA degradation induced by herpes simplex virus infection. J Gen Virol 84:925-928
21. Waterboer T, Rahaus M, Wolff MH (2002) Varicella-zoster virus (VZV) mediates a delayed host shutoff independent of open reading frame (ORF) 17 expression. Virus Genes 24:49-56
22. Yu S-H, Nagayama K, Enomoto N, Izumi N, Marumo F, Sato C (2000) Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C. Hepatology 32:1089-1095
23. Zheng X, Silverman RH, Zhou A, Goto T, Kwon BS, Kaufman HE, Hill JM (2001) Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol Vis Sci 42:120-126